Kyungdong Pharmaceutical Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Kyungdong Pharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Multicenter, Randomized, Double-Blind Phase 3 Trial of KDF1901 in Patients With Essential Hypertension (NCT07116863) | Kyungdong Pharmaceutical Co., Ltd. | 2022-06-21 |
Track Kyungdong Pharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.